Global Ankylosing Spondylitis Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Ankylosing spondylitis is a chronic inflammatory disease that affects the spine. It is a type of arthritis, in which spine bones grow or fuse together, causing the spine to become rigid. Symptoms of ankylosing spondylitis include pain and stiffness from the neck to the lower back, bony fusion, and pain in the ligaments and tendons. These symptomatic changes may be mild or severe, and may lead to a stooped-over posture. The prevalence of ankylosing spondylitis is seen in about 0.1% to 0.5% of the adult population worldwide. It can occur at any age irrespective of gender; however, higher prevalence has been observed among males between the ages of 15?30 years.
SCOPE OF THE REPORT:
This report studies the Ankylosing Spondylitis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ankylosing Spondylitis Treatment market by product type and applications/end industries.
The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.
The increasing prevalence of ankylosing spondylitis itself is a major factor impelling the global ankylosing spondylitis treatment market. In addition, factors such as rising awareness, technological advancements, government initiatives and improvement in the reimbursement scenario augur well for the global ankylosing spondylitis treatment market. However, factors such as high treatment costs and a dearth of experienced professionals are restraining the global ankylosing spondylitis treatment market. In addition, a low adoption rate of ankylosing spondylitis treatment options is restraining the market.
The global Ankylosing Spondylitis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ankylosing Spondylitis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
This report studies the Ankylosing Spondylitis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Ankylosing Spondylitis Treatment market by product type and applications/end industries.
The ankylosing spondylitis treatment market is growing at a significant rate due to the increasing prevalence of ankylosing spondylitis and rising awareness about diagnostics and treatments for the disease. In addition, government initiatives and improving healthcare infrastructure are driving the market for ankylosing spondylitis treatment. However, factors such as the high cost of treatment and lack of skilled surgeons and physiotherapists restrain the market from growing.
The increasing prevalence of ankylosing spondylitis itself is a major factor impelling the global ankylosing spondylitis treatment market. In addition, factors such as rising awareness, technological advancements, government initiatives and improvement in the reimbursement scenario augur well for the global ankylosing spondylitis treatment market. However, factors such as high treatment costs and a dearth of experienced professionals are restraining the global ankylosing spondylitis treatment market. In addition, a low adoption rate of ankylosing spondylitis treatment options is restraining the market.
The global Ankylosing Spondylitis Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ankylosing Spondylitis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- Abbvie
- Amgen
- Janssen Biotech
- Merck
- UCB
- Boehringer Ingelheim
- Johnson & Johnson
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Disease-Modifying Anitrheumatic Drugs (DMARDs)
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Biologics
- Juveniles
- Adults
1 ANKYLOSING SPONDYLITIS TREATMENT MARKET OVERVIEW
1.1 Product Overview and Scope of Ankylosing Spondylitis Treatment
1.2 Classification of Ankylosing Spondylitis Treatment by Types
1.2.1 Global Ankylosing Spondylitis Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Types in 2017
1.2.3 Disease-Modifying Anitrheumatic Drugs (DMARDs)
1.2.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.5 Biologics
1.3 Global Ankylosing Spondylitis Treatment Market by Application
1.3.1 Global Ankylosing Spondylitis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Juveniles
1.3.3 Adults
1.4 Global Ankylosing Spondylitis Treatment Market by Regions
1.4.1 Global Ankylosing Spondylitis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Ankylosing Spondylitis Treatment (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Ankylosing Spondylitis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Ankylosing Spondylitis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Janssen Biotech
2.3.1 Business Overview
2.3.2 Ankylosing Spondylitis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Ankylosing Spondylitis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 UCB
2.5.1 Business Overview
2.5.2 Ankylosing Spondylitis Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 UCB Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Ankylosing Spondylitis Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Ankylosing Spondylitis Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET COMPETITION, BY PLAYERS
3.1 Global Ankylosing Spondylitis Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Ankylosing Spondylitis Treatment Players Market Share
3.2.2 Top 10 Ankylosing Spondylitis Treatment Players Market Share
3.3 Market Competition Trend
4 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SIZE BY REGIONS
4.1 Global Ankylosing Spondylitis Treatment Revenue and Market Share by Regions
4.2 North America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
5.1 North America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
5.2 USA Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6 EUROPE ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
6.1 Europe Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
6.2 Germany Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.4 France Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
7.1 Asia-Pacific Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
7.2 China Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.5 India Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
8.1 South America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
8.2 Brazil Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE ANKYLOSING SPONDYLITIS TREATMENT BY COUNTRIES
9.1 Middle East and Africa Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
10 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Ankylosing Spondylitis Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Ankylosing Spondylitis Treatment Market Forecast by Type (2018-2023)
10.3 Disease-Modifying Anitrheumatic Drugs (DMARDs) Revenue Growth Rate (2013-2023)
10.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2013-2023)
10.5 Biologics Revenue Growth Rate (2013-2023)
11 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2013-2018)
11.2 Ankylosing Spondylitis Treatment Market Forecast by Application (2018-2023)
11.3 Juveniles Revenue Growth (2013-2018)
11.4 Adults Revenue Growth (2013-2018)
12 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SIZE FORECAST (2018-2023)
12.1 Global Ankylosing Spondylitis Treatment Market Size Forecast (2018-2023)
12.2 Global Ankylosing Spondylitis Treatment Market Forecast by Regions (2018-2023)
12.3 North America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.6 South America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Ankylosing Spondylitis Treatment
1.2 Classification of Ankylosing Spondylitis Treatment by Types
1.2.1 Global Ankylosing Spondylitis Treatment Revenue Comparison by Types (2017-2023)
1.2.2 Global Ankylosing Spondylitis Treatment Revenue Market Share by Types in 2017
1.2.3 Disease-Modifying Anitrheumatic Drugs (DMARDs)
1.2.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2.5 Biologics
1.3 Global Ankylosing Spondylitis Treatment Market by Application
1.3.1 Global Ankylosing Spondylitis Treatment Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Juveniles
1.3.3 Adults
1.4 Global Ankylosing Spondylitis Treatment Market by Regions
1.4.1 Global Ankylosing Spondylitis Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Ankylosing Spondylitis Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Ankylosing Spondylitis Treatment (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Ankylosing Spondylitis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Ankylosing Spondylitis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Janssen Biotech
2.3.1 Business Overview
2.3.2 Ankylosing Spondylitis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Biotech Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck
2.4.1 Business Overview
2.4.2 Ankylosing Spondylitis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 UCB
2.5.1 Business Overview
2.5.2 Ankylosing Spondylitis Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 UCB Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Ankylosing Spondylitis Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Ankylosing Spondylitis Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET COMPETITION, BY PLAYERS
3.1 Global Ankylosing Spondylitis Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Ankylosing Spondylitis Treatment Players Market Share
3.2.2 Top 10 Ankylosing Spondylitis Treatment Players Market Share
3.3 Market Competition Trend
4 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SIZE BY REGIONS
4.1 Global Ankylosing Spondylitis Treatment Revenue and Market Share by Regions
4.2 North America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
5.1 North America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
5.2 USA Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6 EUROPE ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
6.1 Europe Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
6.2 Germany Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.4 France Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
7.1 Asia-Pacific Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
7.2 China Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.5 India Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA ANKYLOSING SPONDYLITIS TREATMENT REVENUE BY COUNTRIES
8.1 South America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
8.2 Brazil Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE ANKYLOSING SPONDYLITIS TREATMENT BY COUNTRIES
9.1 Middle East and Africa Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
10 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SEGMENT BY TYPE
10.1 Global Ankylosing Spondylitis Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Ankylosing Spondylitis Treatment Market Forecast by Type (2018-2023)
10.3 Disease-Modifying Anitrheumatic Drugs (DMARDs) Revenue Growth Rate (2013-2023)
10.4 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2013-2023)
10.5 Biologics Revenue Growth Rate (2013-2023)
11 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SEGMENT BY APPLICATION
11.1 Global Ankylosing Spondylitis Treatment Revenue Market Share by Application (2013-2018)
11.2 Ankylosing Spondylitis Treatment Market Forecast by Application (2018-2023)
11.3 Juveniles Revenue Growth (2013-2018)
11.4 Adults Revenue Growth (2013-2018)
12 GLOBAL ANKYLOSING SPONDYLITIS TREATMENT MARKET SIZE FORECAST (2018-2023)
12.1 Global Ankylosing Spondylitis Treatment Market Size Forecast (2018-2023)
12.2 Global Ankylosing Spondylitis Treatment Market Forecast by Regions (2018-2023)
12.3 North America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.6 South America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Ankylosing Spondylitis Treatment Picture
Table Product Specifications of Ankylosing Spondylitis Treatment
Table Global Ankylosing Spondylitis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share by Types in 2017
Figure Disease-Modifying Anitrheumatic Drugs (DMARDs) Picture
Figure Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure Biologics Picture
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Application (2013-2023)
Figure Ankylosing Spondylitis Treatment Revenue Market Share by Applications in 2017
Figure Juveniles Picture
Figure Adults Picture
Table Global Market Ankylosing Spondylitis Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Ankylosing Spondylitis Treatment Type and Applications
Table Abbvie Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Ankylosing Spondylitis Treatment Type and Applications
Table Amgen Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table Janssen Biotech Ankylosing Spondylitis Treatment Type and Applications
Table Janssen Biotech Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Ankylosing Spondylitis Treatment Type and Applications
Table Merck Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Ankylosing Spondylitis Treatment Type and Applications
Table UCB Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Ankylosing Spondylitis Treatment Type and Applications
Table Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Ankylosing Spondylitis Treatment Type and Applications
Table Johnson & Johnson Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Share by Players (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Players in 2016
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Ankylosing Spondylitis Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Ankylosing Spondylitis Treatment Revenue Market Share in 2017
Figure Global Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share by Regions in 2017
Figure North America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure South America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table North America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
Table North America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure USA Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Europe Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure Germany Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure UK Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure France Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure China Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure India Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table South America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
Table South America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure Brazil Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Share by Type (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Type (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Type in 2017
Table Global Ankylosing Spondylitis Treatment Revenue Forecast by Type (2018-2023)
Figure Global Ankylosing Spondylitis Treatment Market Share Forecast by Type (2018-2023)
Figure Global Disease-Modifying Anitrheumatic Drugs (DMARDs) Revenue Growth Rate (2013-2018)
Figure Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2013-2018)
Figure Global Biologics Revenue Growth Rate (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue by Application (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Share by Application (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Application (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Application in 2017
Table Global Ankylosing Spondylitis Treatment Revenue Forecast by Application (2018-2023)
Figure Global Ankylosing Spondylitis Treatment Market Share Forecast by Application (2018-2023)
Figure Global Juveniles Revenue Growth Rate (2013-2018)
Figure Global Adults Revenue Growth Rate (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Europe Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure South America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Ankylosing Spondylitis Treatment Picture
Table Product Specifications of Ankylosing Spondylitis Treatment
Table Global Ankylosing Spondylitis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share by Types in 2017
Figure Disease-Modifying Anitrheumatic Drugs (DMARDs) Picture
Figure Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure Biologics Picture
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Application (2013-2023)
Figure Ankylosing Spondylitis Treatment Revenue Market Share by Applications in 2017
Figure Juveniles Picture
Figure Adults Picture
Table Global Market Ankylosing Spondylitis Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table Abbvie Basic Information, Manufacturing Base and Competitors
Table Abbvie Ankylosing Spondylitis Treatment Type and Applications
Table Abbvie Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Ankylosing Spondylitis Treatment Type and Applications
Table Amgen Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table Janssen Biotech Ankylosing Spondylitis Treatment Type and Applications
Table Janssen Biotech Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Ankylosing Spondylitis Treatment Type and Applications
Table Merck Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Ankylosing Spondylitis Treatment Type and Applications
Table UCB Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Ankylosing Spondylitis Treatment Type and Applications
Table Boehringer Ingelheim Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Ankylosing Spondylitis Treatment Type and Applications
Table Johnson & Johnson Ankylosing Spondylitis Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Share by Players (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Players in 2016
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Ankylosing Spondylitis Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Ankylosing Spondylitis Treatment Revenue Market Share in 2017
Figure Global Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share by Regions in 2017
Figure North America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure South America Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table North America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
Table North America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure USA Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Europe Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure Germany Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure UK Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure France Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure China Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure India Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table South America Ankylosing Spondylitis Treatment Revenue by Countries (2013-2018)
Table South America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure Brazil Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Ankylosing Spondylitis Treatment Revenue and Growth Rate (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Share by Type (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Type (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Type in 2017
Table Global Ankylosing Spondylitis Treatment Revenue Forecast by Type (2018-2023)
Figure Global Ankylosing Spondylitis Treatment Market Share Forecast by Type (2018-2023)
Figure Global Disease-Modifying Anitrheumatic Drugs (DMARDs) Revenue Growth Rate (2013-2018)
Figure Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Growth Rate (2013-2018)
Figure Global Biologics Revenue Growth Rate (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue by Application (2013-2018)
Table Global Ankylosing Spondylitis Treatment Revenue Share by Application (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Application (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue Share by Application in 2017
Table Global Ankylosing Spondylitis Treatment Revenue Forecast by Application (2018-2023)
Figure Global Ankylosing Spondylitis Treatment Market Share Forecast by Application (2018-2023)
Figure Global Juveniles Revenue Growth Rate (2013-2018)
Figure Global Adults Revenue Growth Rate (2013-2018)
Figure Global Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Ankylosing Spondylitis Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Ankylosing Spondylitis Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Europe Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure South America Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Ankylosing Spondylitis Treatment Revenue Market Forecast (2018-2023)
